COVID-19

Risk of Severe Coronavirus Disease 2019 Despite Vaccination in Patients Requiring Treatment with Immune-suppressive Drugs: A Nationwide Cohort Study of US Veterans | Symptoms, Viral Loads, and Rebound among COVID-19 Outpatients Treated with Nirmatrelvir/ritonavir Compared to Propensity Score-matched Untreated Individuals

mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants | Extracting symptoms from free-text responses using ChatGPT among COVID-19 cases in Hong Kong | SARS-CoV-2 Virologic Rebound with Nirmatrelvir–Ritonavir Therapy: An Observational Study

Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected with the Ancestral Strain and Omicron BA.2 Variant in Hong Kong | T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants

Nirmatrelvir/ritonavir Use in Pregnant Women with SARS-CoV-2 Omicron Infection: A Target Trial Emulation | Outcomes of SARS-CoV-2 Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Omicron Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study

Health Worker — Perceived Working Conditions and Symptoms of Poor Mental Health | Mpox Neutralising Antibodies at 6 Months from Mpx Infection or MVA-BN Vaccinations: A Comparative Analysis | Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy | Duration of SARSA-CoV-2 Culturable Virus Shedding in Children

Neurologic Effects of SARS-CoV-2 Transmitted among Dogs | Serotonin reduction in post-acute sequelae of viral infection | Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years | High Influenza Incidence and Disease Severity Among Children and Adolescents Aged <18 Years ― United States, 2022–23 Season

Adult man testing breathing function by spirometry having health problem. Diagnosis of respiratory function in pulmonary disease | Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial | Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome

Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in Coronavirus Disease 2019 Survivors: A Retrospective Cohort Study | SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels | FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19–Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance — 20 States, March 9, 2022–May 31, 2023

Early antibody treatment, inflammation, and risk of post-COVID conditions | Distinguishing features of Long COVID identified through immune profiling | Autonomic dysregulation in long-term patients suffering from Post-COVID-19 Syndrome assessed by heart rate variability | A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes | Inhaled Fluticasone Furoate for Outpatient Treatment of COVID-19 | Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis | Multiorgan MRI findings after hospitalization with COVID-19 in the UK (C-MORE): a prospective, multicenter, observational cohort study

Nirmatrelvir/ritonavir Use and Hospitalizations or Death in Previously Uninfected Non-hospitalized High-risk Population with COVID-19: A matched cohort study | Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis | Vaccination after developing long COVID: impact on clinical presentation, viral persistence and immune responses | Wastewater Surveillance Data as a Complement to Emergency Department Visit Data for Tracking Incidence of Influenza A and Respiratory Syncytial Virus